2018 Mellichamp Lecture: Dr. Shelly Peyton
|Event Date:||October 16, 2018|
|Speaker:||Dr. Shelly Peyton|
|Speaker Affiliation:||University of Massachusetts Amherst|
|Contact Name:||Davidson School of Chemical Engineering
|Open To:||Attendance required for PhD students
|School or Program:||Chemical Engineering
Join us for the 2018 Mellichamp Lecture
Dr. Shelly Peyton
Associate Professor and Barry & Afsaneh Siadat Career Development Faculty Fellow
Department of Chemical Engineering,
University of Massachusetts Amherst
Abstract: Tissue Inspired Hydrogel Design
Improved in vitro models are needed to better understand cancer progression and bridge the gap between in vitro proof-of-concept studies, in vivo validation, and clinical application. Many methods exist to create biomaterial platforms, including hydrogels, which we use to study cells in contexts more akin to what they experience in vivo. Our lab has multiple approaches to create such biomaterials, based on combinations of poly(ethylene glycol) (PEG) with peptides and zwitterions. In this presentation, I will discuss our findings in using these cell culture environments to understand the role of the extracellular matrix (ECM): ligand density, stiffness, geometry, etc., in controlling cancer cell innate drug response via adaptive signaling.
Shelly Peyton is the Barry and Afsaneh Siadat Assistant Professor of Chemical Engineering at the University of Massachusetts, Amherst. She received her B.S. in Chemical Engineering from Northwestern University in 2002 and went on to obtain her MS and PhD in Chemical Engineering from the University of California, Irvine. She was then an NIH Kirschstein post-doctoral fellow in the Biological Engineering department at MIT before starting her academic appointment at UMass in 2011. Shelly Peyton leads an interdisciplinary group seeking to create and apply novel biomaterials platforms toward new solutions to grand challenges in human health. Our unique approach is using our engineering expertise to build simplified models of human tissue with synthetic biomaterials. These tissue mimics are engineered to capture a subset of the mechanical and chemical features of human tissue, and are cheap and reproducible. With these, we study how cell-material interactions in tissues affect drug response toward better patient outcomes. We use these systems to understand 1) the physical relationship between metastatic breast cancer cells and tissues to which they spread, 2) how tissue-specific stem cells remodel tissues to facilitate metastasis, and 3) the role of matrix remodeling in drug resistance. Shelly is a Pew Biomedical Scholar, received a New Innovator Award from the NIH, and she was awarded a CAREER grant from the NSF.
Part of the Fall 2018 Graduate Seminar Series